Clinical Trial Update: Safest Choice of Antihypertensive Regimen for Postpartum Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is evaluating the safest antihypertensive regimen for postpartum hypertension, with recruitment currently ongoing. The sponsor is Loma Li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Maternal Hypertension
• Postpartum Hypertension

Snippet

Sponsor: Loma Linda University | Conditions: Postpartum Complication, Maternal Hypertension | Phase 3 | Status: RECRUITING